Overactive Bladder - Results from #1740

Experience with botulinum toxin type A in the treatment of neurogenic detrusor overactivity in clinical practice - Abstract February 26, 2014

CURE UAB 1st International Congress of Urologic Research and Education on Aging Underactive Bladder: An exclusive report by Diane K. Newman, DNP, ANP-BC, FAAN February 24, 2014

The refractory overactive bladder: Sacral NEuromodulation vs. BoTulinum Toxin Assessment: ROSETTA trial - Abstract February 24, 2014

Single center experience with oxybutynin transdermal system (patch) for management of symptoms related to non-neuropathic overactive bladder in children: An attractive, well tolerated alternative form of administration - Abstract February 20, 2014

A phase III, randomized, double-blind, placebo-controlled study of the β(3) -adrenoceptor agonist, mirabegron 50 mg once-daily, in Japanese patients with overactive bladder - Abstract February 20, 2014

Associations between vitamin C intake and severity of lower urinary tract symptoms by supplemental or dietary intake - Abstract February 19, 2014

Use of desipramine for the treatment of overactive bladder refractory to antimuscarinic therapy - Abstract February 18, 2014

Maintenance of the therapeutic effect of two high-dosage antimuscarinics in the management of overactive bladder in elderly women - Abstract February 14, 2014

Urologic agents for treatment of bladder dysfunction in neurologic disease - Abstract February 14, 2014

Onset of action of the β(3)-adrenoceptor agonist, mirabegron, in Phase II and III clinical trials in patients with overactive bladder - Abstract February 12, 2014

Does fesoterodine have a role in the treatment of poorly managed patients with overactive bladder? - Abstract February 11, 2014

What is the most bothersome lower urinary tract symptom? Individual- and population-level perspectives for both men and women - Abstract February 10, 2014

Therapeutic outcome and patient adherence to repeated onabotulinumtoxinA detrusor injections in chronic spinal cord-injured patients and neurogenic detrusor overactivity - Abstract February 7, 2014

The effect of age on pressure flow parameters in women with lower urinary tract symptoms - Abstract February 6, 2014

Expert consensus on scientific evidence available on the use of botulinum toxin in overactive bladder - Abstract February 5, 2014

Overactive bladder symptom score to evaluate efficacy of solifenacin for the treatment of overactive bladder symptoms - Abstract February 4, 2014

Development and validation of the actionable bladder symptom screening tool for multiple sclerosis patients - Abstract February 3, 2014

Diabetes mellitus does not affect the efficacy and safety of intravesical onabotulinumtoxinA injection in patients with refractory detrusor overactivity - Abstract January 31, 2014

Results of a prospective, randomized, multicenter study evaluating sacral neuromodulation with InterStim therapy compared to standard medical therapy at 6-months in subjects with mild symptoms of overactive bladder - Abstract January 30, 2014

Pharmacological approach to overactive bladder and urge urinary incontinence in women: An overview - Abstract January 29, 2014

Page 88 of 122